New Products
Klaire Labs (SFI USA) Announces the availability of pure Saccharomyces boulardii powder for use in high potency and preventative maintenance protocols
Reno, NV – Klaire Labs (SFI USA) today announced the launch of Saccharomyces boulardii powder. Complete with a dual scoop for measuring accuracy, this clean-label formulation is particularly effective and uniquely convenient for use in high-potency titration protocols. “In response to practitioner requests to simplify protocols recommended by Dr. SidRead
Klaire Labs (SFI USA) Announces the availability of Acumen, the most extensively studied Bacopa monnieri : CDRI 08
Reno, NV – Klaire Labs (SFI USA) today announced the launch of Acumen, the most extensively studied extract of Bacopa monnieri (whole aerial plant extract CDRI 08). CDRI 08 is clinically demonstrated to support spatial working memory,1 new information retention,2 stress management, and mood.3 Bacopa monnieri, commonly known as Brahmi,Read
CVSciences Launches PlusCBD Oil™ Gummies
LAS VEGAS — CV Sciences, Inc. (OTCQB:CVSI) supplier and manufacturer of hemp-derived phytocannabinoids including industry leading brand, PlusCBD Oil™ , announced today that it has introduced PlusCBD Oil™ Gummies at the Natural Product Expo East 2018. A new category of PlusCBD Oil™ products, PlusCBD Oil™ Gummies are offered in twoRead
LifeSeasons Pain Bloc-R for Aches and Discomfort
LifeSeasons® announces availability of Pain Bloc-R, into the practitioner channel. Pain Bloc-R is an award-winning natural supplement shown to help ease everyday aches and discomforts. Pain Bloc-R uses natural compounds and plants like Angelica Root, White Willow Bark, L-Tetrahydro Palmatine, and L-Theanine which work together synergistically for a multi-targeted approachRead
Klaire Labs (SFI USA) Announces a New Probiotic Targeted for Nursing Comfort and Infant Immune Health Support
Klaire Labs (SFI USA) Announces a New Probiotic Targeted for Nursing Comfort and Infant Immune Health Support Target b2™: BREAST and BABY Reno, NV – Klaire Labs (SFI USA) today announced impending availability of a new probiotic, Target b2with Hereditum® Lc40 (Lactobacillus fermentumCECT5716), which is clinically demonstrated to support breastRead
Patient Infographic Posters on Omega-3 Fatty Acids
In partnership with GOED (Global Organization for EPA, DHA, Omega-3s), an industry trade association for Omega-3 fatty acids, we are offering a series of educational patient infographics to place in your patient exam rooms. Each of the seven infographics and videos explains the values of Omega-3 fatty acids for brain,Read
ECS Therapeutics Product Line Release
ECS TherapeuticsTM LLC Announces Introduction of Professional Line of Hemp Extracts Farmingdale, New York (April 23, 2018) – ECS TherapeuticsTM LLC announced the introduction of the first professional line of hemp extracts created for, and exclusively available through, healthcare practitioners. ECS Therapeutics’ full-spectrum hemp oil products supply cannabidiol (CBD) plusRead
Klaire Labs (SFI USA) Announces Availability of Target gb-X™
Reno, NV— Klaire Labs (SFI USA) today announced availability of Target gb-X™ with Ecologic BARRIER, a unique 9-strain blend to support positive mood. This shelf stable, 5B CFU probiotic was specifically designed to influence the gut-brain axis through defined mechanisms including strengthening of the gut barrier function, modulation of cytokinesRead
Allergy Research’s New Immune Support Formula with Immuno-Lp20® & Maritech® Synergy Fucoidan
Allergy Research Group introduces a new immune support product, Fuco-Immune. It contains Maritech® Synergy, a fucoidin seaweed extract, and Lactobacillus plantarum L-137 (Immuno-LP20®), a stable, heat-treated immunobiotic. The company says that together they support respiratory function, a healthy gut lining, and gut immunity, as well as significant antioxidant and anti-inflammatoryRead
Wireless Device Reduces Pressure Injury Risk by 73%
An estimated that more than 2.5 million people suffer from at least one pressure injury each year. There are ways to reduce the risk. A new clinical study by researchers at Stanford Health Care looked at whether a wearable patient sensor could improve patient outcomes at risk for pressure injuries.Read